Literature DB >> 10534324

Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

J L Vanoverschelde1, A Pasquet, B Gerber, J A Melin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10534324      PMCID： PMC1766513          DOI： 10.1136/hrt.82.2008.iii1

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  91 in total

1.  Predictive accuracy of echocardiographic response of mildly dyssynergic myocardial segments to low-dose dobutamine.

Authors:  J H Cornel; J J Bax; A Elhendy; D Poldermans; J L Vanoverschelde; P M Fioretti
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

Review 2.  Chronic myocardial hibernation in humans. From bedside to bench.

Authors:  J L Vanoverschelde; W Wijns; M Borgers; G Heyndrickx; C Depré; W Flameng; J A Melin
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

3.  Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in chronic left ventricular ischemic dysfunction.

Authors:  A Pasquet; A M D'Hondt; J A Melin; J L Vanoverschelde
Journal:  Am J Cardiol       Date:  1998-01-01       Impact factor: 2.778

4.  Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion.

Authors:  T Hata; R Nohara; M Fujita; R Hosokawa; L Lee; T Kudo; E Tadamura; N Tamaki; J Konishi; S Sasayama
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

5.  Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography.

Authors:  J J Bax; J H Cornel; F C Visser; P M Fioretti; A van Lingen; A E Reijs; E Boersma; G J Teule; C A Visser
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

6.  Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium.

Authors:  K T Sun; J Czernin; J Krivokapich; Y K Lau; M Böttcher; G Maurer; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

7.  Myocardial cell death and apoptosis in hibernating myocardium.

Authors:  C Chen; L Ma; D R Linfert; T Lai; J T Fallon; L D Gillam; D D Waters; G J Tsongalis
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

8.  Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function.

Authors:  U Qureshi; S F Nagueh; I Afridi; P Vaduganathan; A Blaustein; M S Verani; W L Winters; W A Zoghbi
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

9.  Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.

Authors:  J L Vanoverschelde; A M D'Hondt; T Marwick; B L Gerber; M De Kock; R Dion; W Wijns; J A Melin
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

10.  Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.

Authors:  P Perrone-Filardi; L Pace; M Prastaro; F Squame; S Betocchi; A Soricelli; F Piscione; C Indolfi; T Crisci; M Salvatore; M Chiariello
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690
View more
  5 in total

Review 1.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

2.  Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium.

Authors:  V Rizzello; D Poldermans; E Biagini; A F L Schinkel; R van Domburg; A Elhendy; E C Vourvouri; M Bountioukos; A Lombardo; B Krenning; J R T C Roelandt; J J Bax
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

3.  Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.

Authors:  T Zaglavara; R Haaverstad; B Cumberledge; T Irvine; H Karvounis; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

4.  Detection of myocardial viability by dobutamine stress echocardiography: incremental value of diastolic wall thickness measurement.

Authors:  T Zaglavara; T Pillay; H Karvounis; R Haaverstad; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  Evidence for an active inflammatory process in the hibernating human myocardium.

Authors:  Nikolaos G Frangogiannis; Sarah Shimoni; Su Min Chang; Guofeng Ren; Kesavan Shan; Constandina Aggeli; Michael J Reardon; George V Letsou; Rafael Espada; Mahesh Ramchandani; Mark L Entman; William A Zoghbi
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.